Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 1426 AL 1440

Decoding Parkinson's disease - iPSC-derived models in the OMICs era

Krach F, Bogiongko ME, Winner B.

Mol Cell Neurosci. 2020 Jul;106:103501. doi: 10.1016/j.mcn.2020.103501. Epub 2020 May 18.

A systems biology approach for studying neurodegenerative diseases

Lam S, Bayraktar A, Zhang C, Turkez H, Nielsen J, Boren J, Shoaie S, Uhlen M, Mardinoglu A.

Drug Discov Today. 2020 Jul;25(7):1146-1159. doi: 10.1016/j.drudis.2020.05.010. Epub 2020 May 19.

Effects of implantation of a deep brain stimulation device on patient weight in Parkinson's disease and essential tremor

Monteferrante NR, Wilhelmi BG, Lambert M, Ponce FA.

J Neurosurg. 2020 May 22;134(5):1624-1630. doi: 10.3171/2020.2.JNS192354. Print 2021 May 1.

Essential tremor vs idiopathic Parkinson disease: Utility of transcranial sonography

Tao A, Chen G, Mao Z, Gao H, Deng Y, Xu R.

Medicine (Baltimore). 2020 May;99(20):e20028. doi: 10.1097/MD.0000000000020028.

Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report

Zhao J, Xu G, Feng C, Chen Y, Kang Y, Liu F, Ma W.

Medicine (Baltimore). 2020 May;99(20):e20129. doi: 10.1097/MD.0000000000020129.

The effect of the Mediterranean diet on cognitive function in patients with Parkinson's disease: A randomized clinical controlled trial

Paknahad Z, Sheklabadi E, Derakhshan Y, Bagherniya M, Chitsaz A.

Complement Ther Med. 2020 May;50:102366. doi: 10.1016/j.ctim.2020.102366. Epub 2020 Mar 4.

The effectiveness of acupuncture for Parkinson's disease: An overview of systematic reviews

Cao L, Li X, Li M, Yao L, Hou L, Zhang W, Wang Y, Niu J, Yang K.

Complement Ther Med. 2020 May;50:102383. doi: 10.1016/j.ctim.2020.102383. Epub 2020 Mar 12.

Personality Dimensions Are Associated with Quality of Life in Fluctuating Parkinson's Disease Patients (PSYCHO-STIM)

Boussac M, Arbus C, Dupouy J, Harroch E, Rousseau V, Ory-Magne F, Rascol O, Moreau C, Maltête D, Rouaud T, Meyer M, Houvenaghel JF, Marsé C, Tranchant C, Hainque E, Jarraya B, Ansquer S, Bonnet M, Belamri L, Tir M, Marques AR, Danaila T, Eusebio A, Devos D, Brefel-Courbon C; PREDI-STIM study group*.

J Parkinsons Dis. 2020;10(3):1057-1066. doi: 10.3233/JPD-191903.

Deep Phenotyping of Parkinson's Disease

Dorsey ER, Omberg L, Waddell E, Adams JL, Adams R, Ali MR, Amodeo K, Arky A, Augustine EF, Dinesh K, Hoque ME, Glidden AM, Jensen-Roberts S, Kabelac Z, Katabi D, Kieburtz K, Kinel DR, Little MA, Lizarraga KJ, Myers T, Riggare S, Rosero SZ, Saria S, Schifitto G, Schneider RB, Sharma G, Shoulson I, Stevenson EA, Tarolli CG, Luo J, McDermott MP.

J Parkinsons Dis. 2020;10(3):855-873. doi: 10.3233/JPD-202006.

The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease

Monzio Compagnoni G, Di Fonzo A, Corti S, Comi GP, Bresolin N, Masliah E.

Mol Neurobiol. 2020 Jul;57(7):2959-2980. doi: 10.1007/s12035-020-01926-1. Epub 2020 May 22.

Biocompatible Nanovesicular Drug Delivery Systems with Targeting Potential for Autoimmune Diseases

Neupane YR, Mahtab A, Siddiqui L, Singh A, Gautam N, Rabbani SA, Goel H, Talegaonkar S.

Curr Pharm Des. 2020;26(42):5488-5502. doi: 10.2174/1381612826666200523174108.

Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson's disease: Potential clinical and therapeutic implications

Angelopoulou E, Paudel YN, Shaikh MF, Piperi C.

Pharmacol Res. 2020 Aug;158:104930. doi: 10.1016/j.phrs.2020.104930. Epub 2020 May 20.

Overview of sleep disturbances and their management in Parkinson plus disorders

Bhattacharya A, Lenka A, Stezin A, Kamble N, Pal PK.

J Neurol Sci. 2020 Aug 15;415:116891. doi: 10.1016/j.jns.2020.116891. Epub 2020 May 8.

Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: A randomized, double-blind, placebo-controlled, phase II/III study

Hattori N, Tsuboi Y, Yamamoto A, Sasagawa Y, Nomoto M; ME2125-3 Study Group.

Parkinsonism Relat Disord. 2020 Jun;75:17-23. doi: 10.1016/j.parkreldis.2020.04.012. Epub 2020 May 4.

Novel ATP13A2 and PINK1 variants identified in Chinese patients with Parkinson's disease by whole-exome sequencing

Chen H, Jin YH, Xue YY, Chen YL, Chen YJ, Tao QQ, Wu ZY.

Neurosci Lett. 2020 Aug 10;733:135075. doi: 10.1016/j.neulet.2020.135075. Epub 2020 May 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias